Mediclinic International PLC
JSE:MEI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (12.3), the stock would be worth Zac11 830 (0% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 12.3 | Zac11 830 |
0%
|
| 3-Year Average | 12.3 | Zac11 830 |
0%
|
| 5-Year Average | 12.3 | Zac11 830 |
0%
|
| Industry Average | 0 | Zac45.73 |
-100%
|
| Country Average | 0 | Zac35.55 |
-100%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Mediclinic International PLC
JSE:MEI
|
3.7B ZAR | 12.3 | 21.9 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
97.1B USD | 17.1 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 250.4 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 41 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 41.6 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 5.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
83.3B BRL | -32.8 | 17.8 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.4B USD | 10.1 | 11 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 26.1 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 108.5 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.8B USD | 27.8 | 31.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0.1 |
| Max | 1 344.9 |
Other Multiples
Mediclinic International PLC
Glance View
Mediclinic International PLC is a fascinating entity in the healthcare sector, with roots deeply planted in South Africa, yet boasting branches that extend into Namibia, Switzerland, and the Middle East. Founded in 1983, Mediclinic has grown over the decades into a reputable provider of private hospital services, focusing on delivering clinical excellence and patient-centered care. Its operations span hospitals, day clinics, and outpatient facilities, which complement one another in creating a comprehensive healthcare network. This synergy allows Mediclinic to cater to various health needs, from simple outpatient procedures to complex surgical interventions, ensuring patients receive holistic and continuous care. The financial heartbeat of Mediclinic stems from its diversified geographical presence and the broad spectrum of services it offers, effectively mitigating risks due to economic or regulatory shifts in any single market. Revenue generation primarily relies on patient fees, encompassing accommodations, medical treatments, and specialist services within their healthcare facilities. Additionally, Mediclinic's strategic investments in cutting-edge medical technology and infrastructure enhance their ability to attract top-tier medical professionals, ensuring that they maintain competitive service offerings in all their regions. As the company navigates the intricacies of varying healthcare systems and legislation, it remains committed to expanding its footprint sustainably while upholding the highest standards in medical practice.